EP2919773A4 - Méthodes de traitement de lésions issues de kératinocytes - Google Patents
Méthodes de traitement de lésions issues de kératinocytesInfo
- Publication number
- EP2919773A4 EP2919773A4 EP13855655.0A EP13855655A EP2919773A4 EP 2919773 A4 EP2919773 A4 EP 2919773A4 EP 13855655 A EP13855655 A EP 13855655A EP 2919773 A4 EP2919773 A4 EP 2919773A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- keratinocytes
- methods
- treating lesions
- lesions
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 210000002510 keratinocyte Anatomy 0.000 title 1
- 230000003902 lesion Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261728210P | 2012-11-19 | 2012-11-19 | |
| PCT/US2013/070833 WO2014078868A1 (fr) | 2012-11-19 | 2013-11-19 | Méthodes de traitement de lésions issues de kératinocytes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP2919773A1 EP2919773A1 (fr) | 2015-09-23 |
| EP2919773A4 true EP2919773A4 (fr) | 2016-11-02 |
Family
ID=50731774
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP13855655.0A Withdrawn EP2919773A4 (fr) | 2012-11-19 | 2013-11-19 | Méthodes de traitement de lésions issues de kératinocytes |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP2919773A4 (fr) |
| WO (1) | WO2014078868A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160128933A1 (en) * | 2014-11-10 | 2016-05-12 | Tiangang Shang | Therapeutic Methods and Compositions |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008065666A2 (fr) * | 2006-11-29 | 2008-06-05 | Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. | Utilisation d'incensole, d'acétate d'incensole et de dérivés correspondants |
| WO2011050095A2 (fr) * | 2009-10-20 | 2011-04-28 | The General Hospital Corporation | Prévention et traitement des dysfonctions cognitives postopératoires (pocd) |
| WO2011163308A2 (fr) * | 2010-06-22 | 2011-12-29 | The General Hospital Corporation | Compositions et méthodes de prévention et de traitement de lésion et/ou de dysfonctionnement d'organe |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07504905A (ja) * | 1992-03-23 | 1995-06-01 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 抗刺激剤として用いるための薬剤 |
| ES2535045T3 (es) * | 2003-04-10 | 2015-05-04 | Vanderbilt Royalty Sub L.P. | Usos y composiciones para administración de capsaicina |
| MX2010011762A (es) * | 2008-06-17 | 2011-02-03 | Glenmark Pharmaceuticals Sa | Derivados de cromano como moduladores del trpv3. |
| KR101034299B1 (ko) * | 2008-12-02 | 2011-05-16 | 고려대학교 산학협력단 | Trpv3 활성 조절 약물 및 이의 활용 |
-
2013
- 2013-11-19 EP EP13855655.0A patent/EP2919773A4/fr not_active Withdrawn
- 2013-11-19 WO PCT/US2013/070833 patent/WO2014078868A1/fr not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008065666A2 (fr) * | 2006-11-29 | 2008-06-05 | Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. | Utilisation d'incensole, d'acétate d'incensole et de dérivés correspondants |
| WO2011050095A2 (fr) * | 2009-10-20 | 2011-04-28 | The General Hospital Corporation | Prévention et traitement des dysfonctions cognitives postopératoires (pocd) |
| WO2011163308A2 (fr) * | 2010-06-22 | 2011-12-29 | The General Hospital Corporation | Compositions et méthodes de prévention et de traitement de lésion et/ou de dysfonctionnement d'organe |
Non-Patent Citations (1)
| Title |
|---|
| See also references of WO2014078868A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2919773A1 (fr) | 2015-09-23 |
| WO2014078868A1 (fr) | 2014-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2760452A4 (fr) | Méthodes de traitement du cancer | |
| EP2552415A4 (fr) | Méthodes de traitement du cancer | |
| EP2892525A4 (fr) | Méthodes de traitement de la dystrophie musculaire | |
| EP2723384A4 (fr) | Traitement de protéinopathies | |
| EP2890720A4 (fr) | Compositions et méthodes de traitement du cancer | |
| EP2911682A4 (fr) | Méthodes de traitement de l'anémie | |
| EP2943192A4 (fr) | Méthodes de traitement du cancer du pancréas | |
| EP2552438A4 (fr) | Méthodes de traitement du carcinome hépatocellulaire | |
| EP2934511A4 (fr) | Méthodes de traitement des spasmes gastro-intestinaux | |
| LT2885010T (lt) | Tautopatijos gydymo būdai | |
| EP2846809A4 (fr) | Traitement de la myélosuppression | |
| EP2854839A4 (fr) | Méthodes de traitement de la maladie c liaque | |
| EP2755482A4 (fr) | Compositions et méthodes de traitement du cancer | |
| EP2932930A4 (fr) | Instrument de traitement | |
| EP2920308A4 (fr) | Traitement du cancer | |
| EP2635286A4 (fr) | Méthodes de traitement du cancer | |
| EP2740419A4 (fr) | Instrument de traitement | |
| EP2908843A4 (fr) | Méthode de traitement du cancer | |
| EP2968191A4 (fr) | Méthodes de traitement du cancer de la vessie | |
| EP2854769A4 (fr) | Méthodes de traitement de l'arthrite | |
| EP2861263A4 (fr) | Compositions et méthodes de traitement du diabète | |
| EP2906580A4 (fr) | Traitement de la sclérose latérale amyotrophique | |
| EP2968253A4 (fr) | Méthodes de traitement de tumeur solide pédiatrique | |
| EP2968273A4 (fr) | Méthodes de traitement de la dystrophie musculaire | |
| EP2882429A4 (fr) | Méthodes de traitement de maladies neurodégénératives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20150602 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| AX | Request for extension of the european patent |
Extension state: BA ME |
|
| DAX | Request for extension of the european patent (deleted) | ||
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 31/69 20060101AFI20160602BHEP Ipc: A61P 35/00 20060101ALI20160602BHEP |
|
| RA4 | Supplementary search report drawn up and despatched (corrected) |
Effective date: 20161005 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 35/00 20060101ALI20160928BHEP Ipc: A61K 31/69 20060101AFI20160928BHEP |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20170503 |